Transcatheter aortic valve implantation: Know the differences between the currently available technologies

European Heart Journal

Volumn 31, Issue 14, 2010, Pages 1663-1665

  MacDonald, Iona ^a   Pasupati, S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; EQUIPMENT DESIGN; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; MEDICAL EDUCATION; NONHUMAN; PACEMAKER; PERICARDIUM; PERICARDIUM LEAFLET; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROSTHESIS FAILURE; REVIEW; STROKE; SURVIVAL RATE; SURVIVAL TIME; TRANSCATHETER AORTIC VALVE DESIGN; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; AORTA VALVE STENOSIS; ARTICLE; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; METHODOLOGY; PROSTHESIS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; AORTIC VALVE STENOSIS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN; STENTS;

EID: 79959575420     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq191     Document Type: Review

References (1)

1. Vahanian A et al. European Association of Cardio-Thoracic Surgery; ESC; European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the ESC, in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;29:1463-1470. (Pubitemid 351806497)